Concepedia
Statistics
Publications
16
Citations
681
H-Index
15
Active since
1998
Affiliations
Novartis (United States)(Current)
Jinan Central Hospital
Shandong University
Shandong First Medical University
Novartis (Switzerland)
Shuya Wang is an author at Novartis (United States) specializing in pharmacology, medicine, and ion channel pharmacology.
Publications per year
1998–2023
Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
S. L. Hu, Shuya Wang, Brian Fanelli et al. · PubMed · 2000 · 127 citations
Medicine, Biochemistry, Pharmacology +17
microRNA-21 regulates astrocytic reaction post-acute phase of spinal cord injury through modulating TGF-β signaling
Ronghan Liu, Wenzhao Wang, Shuya Wang et al. · Aging · 2018 · 76 citations · Full text
Medicine, Neurobiology, Neuroscience +17
Pancreatic β-Cell KATP Channel Activity and Membrane-Binding Studies with Nateglinide: A Comparison with Sulfonylureas and Repaglinide
Shiling Hu, Shuya Wang, Barbara Fanelli et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 69 citations
Medicine, Biochemistry, Pharmacology +14
Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.
S. L. Hu, Shuya Wang, Beth E. Dunning · PubMed · 1999 · 63 citations
Medicine, Cardiology, Pharmacology +17
Fexofenadine inhibits TNF signaling through targeting to cytosolic phospholipase A2 and is therapeutic against inflammatory arthritis
Ronghan Liu, Yuehong Chen, Wenyu Fu et al. · Annals of the Rheumatic Diseases · 2019 · 58 citations · Full text
Medicine, Immunology, Pharmacology +17
1–5 of 16